当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Steps forward for cancer precision medicine
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2017-11-24 , DOI: 10.1038/nrd.2017.218
Roberto Salgado , , Helen Moore , John W. M. Martens , Tracy Lively , Shakun Malik , Ultan McDermott , Stefan Michiels , Jeffrey A. Moscow , Sabine Tejpar , Tawnya McKee , Denis Lacombe

Steps forward for cancer precision medicine

Steps forward for cancer precision medicine, Published online: 24 November 2017; doi:10.1038/nrd.2017.218

The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice.


中文翻译:

癌症精准医学的新进展

癌症精准医学的新进展

癌症精准医学的新进展,在线发布:2017年11月24日;doi:10.1038 / nrd.2017.218

靶向抗癌药的可获得性和基因组分析的相对可承受性已经导致癌症患者对他们可以根据肿瘤的基因组特征接受个性化治疗的期望越来越高。在这里,我们讨论了将此类方法引入常规实践所需的一些挑战和步骤。
更新日期:2017-11-24
down
wechat
bug